FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Dantrolene sodium 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Dantrolene sodium 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely carmustine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
céfotaxime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
céfotaxime 500 mg, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Alprostadil 20 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Alprostadil 20 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
céfotaxime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheal instillation (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Alprostadil 40 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Alprostadil 40 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Doripenem (as doripenem monohydrate) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Doripenem (as doripenem monohydrate) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Alprostadil 5 microgram powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Alprostadil 5 microgram powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Alteplase 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Alteplase 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
aztréonam 500 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
aztréonam 500 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
céfoxitine 2 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 2
aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Amobarbital sodium 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Amobarbital sodium 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Basiliximab 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Basiliximab 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
céfuroxime 250 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
céfuroxime 250 mg, fiole de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Basiliximab 20 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Basiliximab 20 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
chlorhydrate de diacétylmorphine 10 mg, pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 10 mg, pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 2
chlorhydrate de diacétylmorphine 30 mg, pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 30 mg, pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 100 mg, pour injection (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 100 mg, pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 500 mg, pour injection Has presentation strength denominator value False un Inferred relationship Some 1
chlorhydrate de diacétylmorphine 500 mg, pour injection Count of base of active ingredient False un Inferred relationship Some
Doxorubicin hydrochloride 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Doxorubicin hydrochloride 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ceftazidime 1 g, pour injection (poudre pour reconstitution) (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Disodium pamidronate 90 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Disodium pamidronate 90 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Disodium pamidronate 30 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Disodium pamidronate 30 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
ceftazidime 250 mg, flacon de poudre pour solution injectable (médicament clinique) Has presentation strength denominator value False un Inferred relationship Some 1
ceftazidime 250 mg, flacon de poudre pour solution injectable (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
Cyclophosphamide (as cyclophosphamide monohydrate) 1 g powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Cyclophosphamide (as cyclophosphamide monohydrate) 1 g powder for solution for injection vial Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Cyclophosphamide (as cyclophosphamide monohydrate) 1 g powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) Count of base of active ingredient False un Inferred relationship Some
chloramphénicol 1 g, fiole de poudre pour injection (médicament clinique) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1

Start Previous Page 182 of 217 Next End

This concept is not in any reference sets

Back to Start